Investment analysts at Lifesci Capital issued their Q1 2025 earnings per share (EPS) estimates for shares of Perspective ...

In a report released today, Charles Zhu from LifeSci Capital maintained a Hold rating on Repare Therapeutics (RPTX – Research Report). The ...

Aura Biosciences (NASDAQ:AURA – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a ...